S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

ITRM Iterum Therapeutics PLC

1.235

-0.025 (-1.98%)

Last Updated: 03:36:14

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

0000950170-25-015857.txt

Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Iterum Therapeutics Charts.

Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Iterum Therapeutics Charts.

Iterum Therapeutics PLC News

Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
Monday 14 April 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 18 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 10 March 2025 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Thursday 20 February 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 15 February 2025 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Saturday 8 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 7 February 2025 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 7 February 2025 (3 months ago) • Edgar (US Regulatory)

Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
Friday 7 February 2025 (3 months ago) • GlobeNewswire Inc.

Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025
Saturday 1 February 2025 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 11 December 2024 (5 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 10 December 2024 (5 months ago) • Edgar (US Regulatory)

More Iterum Therapeutics PLC News Articles

Fundo Invest Imobiliario...

Credit Mutuel Arkea null

SPDR Nuveen Municipal

Cadence Minerals

New Zealand Government

Banque Postalela null

Credit Agricole SA 2.1% ...

BNP Paribas SA Bnp Parib...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions